Clinical Trials Logo
  1. Home
  2. Growth Disorder
  3. NCT00174421

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Growth Disorder Clinical Trial

Official title:
Genotropin in Short Children Born Small for Gestational Ag - A Long-Term Study in Belgium

Clinical Trial Summary

This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00174421
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date April 2001
Completion date August 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT01943084 - A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects Phase 1
Completed NCT02580032 - Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Completed NCT00001190 - Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature Phase 2
Completed NCT01578135 - French National Registry of Children Born Small for Gestational Age Treated With Somatropin
Completed NCT01401244 - Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers Phase 1
Recruiting NCT02769975 - Evaluation of Children With Endocrine and Metabolic-Related Conditions
Completed NCT01778023 - Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature Phase 3
Completed NCT01543867 - Safety and Efficacy of Long-term Somatropin Treatment in Children N/A
Completed NCT00191074 - Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature Phase 3
Terminated NCT02311322 - Genetic Causes of Growth Disorders
Withdrawn NCT01512095 - Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers Phase 1
Completed NCT00262249 - Effect of Growth Hormone in Children With Growth Hormone Deficiency Phase 3
Completed NCT02428296 - Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation Phase 2